======= CYP2A6 ======= == Gene Information == * **Official Symbol**: CYP2A6 * **Official Name**: cytochrome P450 family 2 subfamily A member 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1548|1548]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11509|P11509]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CYP2A6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP2A6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/122720|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |p450| |coumarin 7-hydroxylase activity| |phenylpropanoid catabolic process| |coumarin catabolic process| |coumarin metabolic process| |phenylpropanoid metabolic process| |arachidonic acid epoxygenase activity| |epoxygenase P450 pathway| |exogenous drug catabolic process| |oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen| |steroid hydroxylase activity| |cytoplasmic microtubule| |secondary metabolic process| |arachidonic acid metabolic process| |unsaturated fatty acid metabolic process| |icosanoid metabolic process| |long-chain fatty acid metabolic process| |xenobiotic metabolic process| |iron ion binding| |heme binding| |drug catabolic process| |fatty acid derivative metabolic process| |cellular response to xenobiotic stimulus| |steroid metabolic process| |response to xenobiotic stimulus| |fatty acid metabolic process| |enzyme binding| |heterocycle catabolic process| |aromatic compound catabolic process| |organic cyclic compound catabolic process| |drug metabolic process| |monocarboxylic acid metabolic process| |intracellular membrane-bounded organelle| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |response to drug| |organic acid metabolic process| |lipid metabolic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13501 * **Expression level (log2 read counts)**: -4.01 {{:chemogenomics:nalm6 dist.png?nolink |}}